Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1Phase 1/2 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 3

Sponsor

Conditions

Neoplasms 2875Carcinoma, Non-Small-Cell Lung 2428Breast Neoplasms 2068Colorectal Neoplasms 1247Neoplasm Metastasis 1232Prostatic Neoplasms 1080Melanoma 974Multiple Myeloma 963Ovarian Neoplasms 904Recurrence 852Leukemia, Myeloid, Acute 810Lung Neoplasms 758Pancreatic Neoplasms 753Lymphoma, Non-Hodgkin 727Lymphoma 660Stomach Neoplasms 623Carcinoma, Hepatocellular 566Carcinoma, Renal Cell 546Squamous Cell Carcinoma of Head and Neck 529Leukemia, Lymphocytic, Chronic, B-Cell 493Lymphoma, Follicular 468Head and Neck Neoplasms 451Glioblastoma 436Advanced Solid Tumors 432Small Cell Lung Carcinoma 411Triple Negative Breast Neoplasms 410Lymphoma, Large B-Cell, Diffuse 398Leukemia 394Uterine Cervical Neoplasms 369Advanced Solid Tumor 351

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Recurrent respiratory papillomatosis × Clear all
NCT06538480 2025-12-15

Zopa Retreatment and Vector Shedding in Adults With RRP

Precigen, Inc

Phase 4 Recruiting
30 enrolled

Recurrent respiratory papillomatosis, Papillomavirus Infections

NCT04724980 2025-06-11

Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis

Precigen, Inc

Phase 1/2 Active not recruiting
38 enrolled

Recurrent respiratory papillomatosis, Papillomavirus Infections

NCT00038714 2007-06-27

A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis

Nventa Biopharmaceuticals Corporation

Phase 2 Completed
27 enrolled

Recurrent respiratory papillomatosis, Papilloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡